Aim:This study aimed to screen the potential phytochemicals derived from
Asparagus racemosus (Shatavari) against Thymidylate Kinase (TMPK) and D9 decapping
enzyme, which is the vital target of the monkeypox virus and helps in the host--
pathogen interaction mechanism, using integrated docking, QSAR analysis, and a molecular
dynamics approach.Background:The Monkeypox Virus (MPXV) is a recently emerging outbreak with ongoing
infection cases. Drugs and vaccines for smallpox are being used to contain it.
However, no specific drugs or vaccines are available to combat this infection.Methods:The TMPK and D9 decapping enzymes were retrieved from the MPXV virus
UK strain in FASTA format. Due to the unavailability of an experimentally determined
structure, the 3D structure was modelled via SWISS-MODEL and further enhanced and
validated. The structure was subjected to docking analysis with the derived phytochemicals
from Asparagus racemosus using a maestro module. The potential inhibitors were
examined via QSAR analysis. Additionally, through MD simulation 250ns, the stability
was analyzed, and the MM-GBSA was employed to calculate the binding affinities.Results:The molecular investigation revealed asparoside-C (PubChem ID: 158598) and
asparoside-D (PubChem ID: 158597) to be potential hits among others for both targets
(TMPK and D9 decapping enzyme) compared to the reference drugs, i.e., tecovirimat,
brincidofovir, and cidofovir, possessing antiviral and required bioactivity analyzed via
the ADME and QSAR analyses. Moreover, the simulation study of over 250ns revealed
strong stability, followed by RMSD, RMSF, etc. The free energy calculation via MMGBSA
exhibited strong affinities of asparoside-C and asparoside-D towards the TMPK
and the D9 decapping enzyme according to their respective scores.result:The molecular investigation revealed Asparoside-C; (PubChem ID: 158598) and Asparoside-D (PubChem ID: 158597) as potential hits among others for both targets (TMPK and D9 decapping enzyme) compared to the reference drugs, i.e., Tecovirimat, Brincidofovir, and Cidofovir and also possess antiviral and required bioactivity analysed via the ADME and QSAR analysis. Moreover, the simulation study of over 250ns revealed strong stability, followed by their RMSD, RMSF, etc. The free energy calculation via MM-GBSA exhibited strong affinities of Asparoside-C and Asparoside-D towards the TMPK and the D9 decapping enzyme by their respective scores.Conclusion:The docking, QSAR, and simulation investigation revealed dual-target inhibitors
activity of phytochemicals from Asparagus racemosus towards the MPXV via
targeting TMPK and D9 decapping enzyme. It has been observed that asparoside-D and
asparoside-C can potentially combat MPXV.